BR9914699B1 - método para extração de frações de lipìdios de material de animais marinhos e aquáticos, extrato de lipìdio de cril, uso do mesmo, fração de lipìdio, e, uso da mesma. - Google Patents

método para extração de frações de lipìdios de material de animais marinhos e aquáticos, extrato de lipìdio de cril, uso do mesmo, fração de lipìdio, e, uso da mesma. Download PDF

Info

Publication number: BR9914699B1
Authority: BR; Brazil
Prior art keywords: lipid; extraction; cril; solvent; fraction
Prior art date: 1998-10-21

Application number

BRPI9914699-1A

Other languages

English (en)

Portuguese (pt)

Other versions

BR9914699A (pt

Inventor

Adrien Beaudoin

Genevi Ve Martin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-21

Filing date

1999-10-21

Publication date

2009-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4162941&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9914699(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-21 Application filed filed Critical

2001-07-10 Publication of BR9914699A publication Critical patent/BR9914699A/pt

2009-12-01 Publication of BR9914699B1 publication Critical patent/BR9914699B1/pt

Links

150000002632 lipids Chemical class 0.000 title claims abstract description 97
238000000034 method Methods 0.000 title claims abstract description 76
241001465754 Metazoa Species 0.000 title claims abstract description 34
239000000284 extract Substances 0.000 title claims abstract description 18
239000000463 material Substances 0.000 title claims abstract description 17
238000000605 extraction Methods 0.000 claims abstract description 134
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 59
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 42
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims abstract description 22
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 14
108090000790 Enzymes Proteins 0.000 claims abstract description 13
102000004190 Enzymes Human genes 0.000 claims abstract description 13
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 100
239000002904 solvent Substances 0.000 claims description 54
230000008569 process Effects 0.000 claims description 34
241000251468 Actinopterygii Species 0.000 claims description 26
239000007787 solid Substances 0.000 claims description 15
241000239263 Calanus Species 0.000 claims description 14
FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 14
238000001704 evaporation Methods 0.000 claims description 9
239000007788 liquid Substances 0.000 claims description 8
JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 7
OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 7
235000013793 astaxanthin Nutrition 0.000 claims description 7
MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 7
239000001168 astaxanthin Substances 0.000 claims description 7
229940022405 astaxanthin Drugs 0.000 claims description 7
235000012682 canthaxanthin Nutrition 0.000 claims description 7
239000001659 canthaxanthin Substances 0.000 claims description 7
229940008033 canthaxanthin Drugs 0.000 claims description 7
230000008020 evaporation Effects 0.000 claims description 7
239000003960 organic solvent Substances 0.000 claims description 7
235000021466 carotenoid Nutrition 0.000 claims description 6
150000001747 carotenoids Chemical class 0.000 claims description 6
239000002537 cosmetic Substances 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 6
239000000047 product Substances 0.000 claims description 6
239000002417 nutraceutical Substances 0.000 claims description 5
150000002576 ketones Chemical class 0.000 claims description 4
239000012298 atmosphere Substances 0.000 claims description 3
239000006227 byproduct Substances 0.000 claims description 3
238000005119 centrifugation Methods 0.000 claims description 3
150000002168 ethanoic acid esters Chemical class 0.000 claims description 3
238000001914 filtration Methods 0.000 claims description 3
238000009395 breeding Methods 0.000 claims description 2
230000001488 breeding effect Effects 0.000 claims description 2
230000006837 decompression Effects 0.000 claims description 2
239000002245 particle Substances 0.000 claims description 2
238000001694 spray drying Methods 0.000 claims description 2
238000009372 pisciculture Methods 0.000 claims 3
238000005406 washing Methods 0.000 claims 3
239000011261 inert gas Substances 0.000 claims 1
238000007560 sedimentation technique Methods 0.000 claims 1
238000007738 vacuum evaporation Methods 0.000 claims 1
102000004169 proteins and genes Human genes 0.000 abstract description 12
108090000623 proteins and genes Proteins 0.000 abstract description 12
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 6
238000003811 acetone extraction Methods 0.000 abstract description 4
241000239366 Euphausiacea Species 0.000 abstract description 2
238000000638 solvent extraction Methods 0.000 abstract description 2
150000002148 esters Chemical class 0.000 abstract 1
239000003921 oil Substances 0.000 description 28
235000019198 oils Nutrition 0.000 description 26
235000019688 fish Nutrition 0.000 description 24
235000014113 dietary fatty acids Nutrition 0.000 description 22
229930195729 fatty acid Natural products 0.000 description 22
239000000194 fatty acid Substances 0.000 description 22
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
150000004665 fatty acids Chemical class 0.000 description 20
241001472118 Euphausia pacifica Species 0.000 description 16
210000001519 tissue Anatomy 0.000 description 13
238000004809 thin layer chromatography Methods 0.000 description 12
235000018102 proteins Nutrition 0.000 description 11
238000005516 engineering process Methods 0.000 description 10
239000000203 mixture Substances 0.000 description 10
238000011084 recovery Methods 0.000 description 10
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
241000894007 species Species 0.000 description 9
238000011534 incubation Methods 0.000 description 8
230000007935 neutral effect Effects 0.000 description 8
150000003904 phospholipids Chemical class 0.000 description 8
WRCITXQNXAIKLR-UHFFFAOYSA-N tiadenol Chemical compound OCCSCCCCCCCCCCSCCO WRCITXQNXAIKLR-UHFFFAOYSA-N 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
241001486234 Sciota Species 0.000 description 7
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
238000001030 gas--liquid chromatography Methods 0.000 description 6
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
239000010775 animal oil Substances 0.000 description 5
229910052740 iodine Inorganic materials 0.000 description 5
239000011630 iodine Substances 0.000 description 5
210000001835 viscera Anatomy 0.000 description 5
241000251730 Chondrichthyes Species 0.000 description 4
239000003963 antioxidant agent Substances 0.000 description 4
235000006708 antioxidants Nutrition 0.000 description 4
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
241000212925 Meganyctiphanes norvegica Species 0.000 description 3
241000277331 Salmonidae Species 0.000 description 3
241000269821 Scombridae Species 0.000 description 3
235000019169 all-trans-retinol Nutrition 0.000 description 3
239000011717 all-trans-retinol Substances 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
230000037213 diet Effects 0.000 description 3
230000000694 effects Effects 0.000 description 3
235000006486 human diet Nutrition 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
235000020640 mackerel Nutrition 0.000 description 3
239000012071 phase Substances 0.000 description 3
230000002797 proteolythic effect Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000283153 Cetacea Species 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
208000025865 Ulcer Diseases 0.000 description 2
-1 acetone Chemical class 0.000 description 2
229940100609 all-trans-retinol Drugs 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
230000003078 antioxidant effect Effects 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
230000018044 dehydration Effects 0.000 description 2
238000006297 dehydration reaction Methods 0.000 description 2
235000020774 essential nutrients Nutrition 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
235000019197 fats Nutrition 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
229940013317 fish oils Drugs 0.000 description 2
238000002955 isolation Methods 0.000 description 2
206010025135 lupus erythematosus Diseases 0.000 description 2
235000013372 meat Nutrition 0.000 description 2
239000002609 medium Substances 0.000 description 2
238000013508 migration Methods 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000003801 milling Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
235000020660 omega-3 fatty acid Nutrition 0.000 description 2
150000002978 peroxides Chemical class 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000007127 saponification reaction Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000002798 spectrophotometry method Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
238000011282 treatment Methods 0.000 description 2
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
231100000397 ulcer Toxicity 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
235000021122 unsaturated fatty acids Nutrition 0.000 description 2
150000004670 unsaturated fatty acids Chemical class 0.000 description 2
239000002699 waste material Substances 0.000 description 2
241000894006 Bacteria Species 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
241000252203 Clupea harengus Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241001669573 Galeorhinus galeus Species 0.000 description 1
241001303079 Galeus Species 0.000 description 1
102000014171 Milk Proteins Human genes 0.000 description 1
108010011756 Milk Proteins Proteins 0.000 description 1
241000170625 Mustelus schmitti Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
241000199919 Phaeophyceae Species 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
241000680651 Thysanoessa raschii Species 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000013019 agitation Methods 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
229940087168 alpha tocopherol Drugs 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000004641 brain development Effects 0.000 description 1
239000001273 butane Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
229940107161 cholesterol Drugs 0.000 description 1
239000003026 cod liver oil Substances 0.000 description 1
235000012716 cod liver oil Nutrition 0.000 description 1
239000006071 cream Substances 0.000 description 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 1
MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001647 drug administration Methods 0.000 description 1
235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
229960005135 eicosapentaenoic acid Drugs 0.000 description 1
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
239000010462 extra virgin olive oil Substances 0.000 description 1
235000021010 extra-virgin olive oil Nutrition 0.000 description 1
230000004373 eye development Effects 0.000 description 1
239000004744 fabric Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000002030 fractions by solvent Substances 0.000 description 1
235000021588 free fatty acids Nutrition 0.000 description 1
238000004817 gas chromatography Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
238000000892 gravimetry Methods 0.000 description 1
238000000227 grinding Methods 0.000 description 1
235000019514 herring Nutrition 0.000 description 1
125000004836 hexamethylene group Chemical class [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
239000012535 impurity Substances 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
229940106134 krill oil Drugs 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
235000021239 milk protein Nutrition 0.000 description 1
IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
235000019645 odor Nutrition 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
229940012843 omega-3 fatty acid Drugs 0.000 description 1
239000006014 omega-3 oil Substances 0.000 description 1
BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
239000000123 paper Substances 0.000 description 1
125000004817 pentamethylene group Chemical class [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
SDRZXZKXVBHREH-UHFFFAOYSA-M potassium;dihydrogen phosphate;phosphoric acid Chemical compound [K+].OP(O)(O)=O.OP(O)([O-])=O SDRZXZKXVBHREH-UHFFFAOYSA-M 0.000 description 1
244000144977 poultry Species 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000001294 propane Substances 0.000 description 1
238000010992 reflux Methods 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000011343 solid material Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000012265 solid product Substances 0.000 description 1
238000000935 solvent evaporation Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
235000019640 taste Nutrition 0.000 description 1
238000012360 testing method Methods 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960000984 tocofersolan Drugs 0.000 description 1
235000010384 tocopherol Nutrition 0.000 description 1
229930003799 tocopherol Natural products 0.000 description 1
239000011732 tocopherol Substances 0.000 description 1
229960001295 tocopherol Drugs 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000003253 viricidal effect Effects 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
235000005282 vitamin D3 Nutrition 0.000 description 1
239000011647 vitamin D3 Substances 0.000 description 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
229940021056 vitamin d3 Drugs 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
238000009736 wetting Methods 0.000 description 1
235000004835 α-tocopherol Nutrition 0.000 description 1
239000002076 α-tocopherol Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Oil, Petroleum & Natural Gas (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Fats And Perfumes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cosmetics (AREA)
Fodder In General (AREA)
Edible Oils And Fats (AREA)
Farming Of Fish And Shellfish (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Feed For Specific Animals (AREA)
Meat, Egg Or Seafood Products (AREA)

BRPI9914699-1A 1998-10-21 1999-10-21 método para extração de frações de lipìdios de material de animais marinhos e aquáticos, extrato de lipìdio de cril, uso do mesmo, fração de lipìdio, e, uso da mesma. BR9914699B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CA2,251,265		1998-10-21
CA002251265A CA2251265A1 (en)	1998-10-21	1998-10-21	Process for lipid extraction of aquatic animal tissues producing a dehydrated residue
PCT/CA1999/000987 WO2000023546A1 (en)	1998-10-21	1999-10-21	Method of extracting lipids from marine and aquatic animal tissues

Publications (2)

Publication Number	Publication Date
BR9914699A BR9914699A (pt)	2001-07-10
BR9914699B1 true BR9914699B1 (pt)	2009-12-01

Family

ID=4162941

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9914699-1A BR9914699B1 (pt)	1998-10-21	1999-10-21	método para extração de frações de lipìdios de material de animais marinhos e aquáticos, extrato de lipìdio de cril, uso do mesmo, fração de lipìdio, e, uso da mesma.

Country Status (19)

Country	Link
US (1)	US6800299B1 (ja)
EP (1)	EP1123368B1 (ja)
JP (2)	JP4181305B2 (ja)
KR (1)	KR100454899B1 (ja)
CN (1)	CN1269940C (ja)
AT (1)	ATE391763T1 (ja)
AU (1)	AU765464B2 (ja)
BR (1)	BR9914699B1 (ja)
CA (1)	CA2251265A1 (ja)
DE (1)	DE69938504T2 (ja)
DK (1)	DK1123368T3 (ja)
ES (1)	ES2306527T3 (ja)
NO (1)	NO321481B1 (ja)
PL (1)	PL201771B1 (ja)
PT (1)	PT1123368E (ja)
RU (1)	RU2236441C2 (ja)
UA (1)	UA75029C2 (ja)
WO (1)	WO2000023546A1 (ja)
ZA (1)	ZA200103235B (ja)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2251265A1 (en) *	1998-10-21	2000-04-21	Universite De Sherbrooke	Process for lipid extraction of aquatic animal tissues producing a dehydrated residue
AUPQ480399A0 (en) *	1999-12-22	2000-02-03	Commonwealth Scientific And Industrial Research Organisation	Unsaturated fatty acids and their uses in therapy
CN102319266B (zh) *	2001-06-18	2014-12-17	海王星技术&生物资源有限公司	用于预防和/或治疗心血管疾病、关节炎、皮肤癌、糖尿病、经前综合症和透皮转运的磷虾和/或海产提取物
AU2013205516B2 (en) *	2001-07-27	2014-04-24	Aker Biomarine Antarctic As	Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
PT1417211E (pt)	2001-07-27	2007-08-28	Neptune Technologies & Bioress	Fosfolípidos naturais de origem marinha contendo flavonóides e fosfolípidos polinsaturados e suas utilizações.
US20050130937A1 (en)	2003-10-22	2005-06-16	Enzymotec Ltd.	Lipids containing omega-3 and omega-6 fatty acids
US7935365B2 (en)	2003-10-22	2011-05-03	Enzymotec, Ltd.	Glycerophospholipids for the improvement of cognitive functions
US8052992B2 (en)	2003-10-22	2011-11-08	Enzymotec Ltd.	Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
EP1716221B1 (en) *	2004-01-30	2008-11-05	Bionovate Limited	Solvent extraction of lipids from perna canaliculus
EP1727882A4 (en) *	2004-02-06	2008-12-10	Adrien Beaudoin	PROCESS FOR PREVENTING OXIDATION OF LIPIDS IN ANIMAL AND VEGETABLE OILS AND COMPOSITIONS PRODUCED ACCORDING TO SAID METHOD
US7666447B2 (en) *	2004-10-08	2010-02-23	Pharmanutrients	Compositions including Krill extracts and conjugated linoleic acid and methods of using same
US8404875B2 (en)	2005-02-07	2013-03-26	Adrien Beaudoin	Method for preventing the oxidation of lipids in animal and vegetable oils and compositions produced by the method thereof
GB0506788D0 (en) *	2005-04-04	2005-05-11	Biosea Man As	Process
RU2325801C2 (ru) *	2006-01-10	2008-06-10	Федеральное государственное унитарное предприятие "Каспийский научно-исследовательский институт рыбного хозяйства" (ФГУП "КаспНИРХ")	Способ оценки потенциально готовых к нерестовым миграциям самок воблы
WO2007080514A2 (en) *	2006-01-13	2007-07-19	Krill A/S	A method for the extraction of lipid fractions from krill
WO2008050219A2 (en) *	2006-10-24	2008-05-02	Krill A/S	Method and equipment' for improved extraction of lipid fractions from aquatic animals and from marine origin
JP2010510208A (ja) *	2006-11-16	2010-04-02	プロノヴァバイオファーマノルゲアーエス	オキアミ油およびミールの製造方法
JP2008239500A (ja) *	2007-03-25	2008-10-09	Nippon Suisan Kaisha Ltd	レプチン分泌促進剤
AU2011213836B2 (en) *	2007-03-28	2013-11-14	Aker Biomarine Antarctic As	Bioeffective krill oil compositions
US8697138B2 (en)	2007-03-28	2014-04-15	Aker Biomarine As	Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
AU2014100739B4 (en) *	2007-03-28	2014-11-20	Aker Biomarine Antarctic As	Processes and products thereof
CA2682068C (en)	2007-03-28	2017-11-28	Aker Biomarine Asa	Bioeffective krill oil compositions
US20080254135A1 (en) *	2007-04-10	2008-10-16	Marvin Heuer	Resveratrol-containing compositions for general health and vitality
US20100226977A1 (en) *	2007-08-29	2010-09-09	Aker Biomarine Asa	Low viscosity phospholipid compositions
AU2008291978B2 (en) *	2007-08-29	2012-08-09	Aker Biomarine Antarctic As	A new method for making krill meal
AU2014100741B4 (en) *	2007-08-29	2014-09-11	Aker Biomarine Antarctic As	Processes and products thereof
EP2110027A1 (en) *	2008-04-01	2009-10-21	Nestec S.A.	Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
WO2009139641A1 (en) *	2008-05-15	2009-11-19	Pronova Biopharma Norge As	Krill oil process
US9814256B2 (en)	2009-09-14	2017-11-14	Rimfrost Technologies As	Method for processing crustaceans to produce low fluoride/low trimethyl amine products thereof
DK3238551T3 (da)	2008-09-12	2020-03-02	Rimfrost Tech As	Proces til reduktion af fluoridindholdet ved fremstilling af proteinøse koncentrater ud fra krill
US8557297B2 (en)	2008-09-12	2013-10-15	Olympic Seafood, As	Method for processing crustaceans and products thereof
US20100077654A1 (en) *	2008-09-23	2010-04-01	LiveFuels, Inc.	Systems and methods for producing biofuels from algae
JP5703021B2 (ja) *	2008-09-26	2015-04-15	日本水産株式会社	脂質の濃縮方法
WO2010038964A2 (ko) *	2008-09-30	2010-04-08	주식회사 유맥스	크릴로부터 유용성분 추출분리방법 및 관련 제품
KR101024491B1 (ko) *	2008-12-31	2011-03-31	인성실업(주)	해양 동물로부터 지질을 추출하는 방법
WO2010077152A1 (en)	2009-01-05	2010-07-08	Calanus As	Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
CA2752675A1 (en)	2009-02-18	2010-08-26	Walsh Intellectual Property Ltd.	A tubular duct member
US8372812B2 (en)	2009-02-26	2013-02-12	Aker Biomarine Asa	Phospholipid and protein tablets
WO2010121094A1 (en)	2009-04-17	2010-10-21	Livefuels. Inc.	Systems and methods for culturing algae with bivalves
CA2763647A1 (en)	2009-05-28	2010-12-02	Aker Biomarine Asa	Methods of using krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders
CN102802428B (zh)	2009-06-12	2016-06-29	卡勒纳斯公司	油组合物，包含所述油组合物的制剂，及其减少内脏脂肪蓄积、改善葡萄糖耐量和预防或治疗肥胖相关疾病和病症的应用
WO2010147955A1 (en) *	2009-06-16	2010-12-23	LiveFuels, Inc.	Systems and methods for harvesting algae
US8557275B2 (en)	2009-07-23	2013-10-15	U.S. Nutraceuticals, LLC	Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9913810B2 (en)	2009-07-23	2018-03-13	U.S. Nutraceuticals, LLC	Composition and method to alleviate joint pain using phospholipids and astaxanthin
US9238043B2 (en)	2009-07-23	2016-01-19	U.S. Nutraceuticals, LLC	Composition and method to alleviate joint pain using algae based oils
US9216164B2 (en)	2009-07-23	2015-12-22	U.S. Nutraceuticals, LLC	Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9399047B2 (en)	2009-07-23	2016-07-26	U.S. Nutraceuticals, LLC	Composition and method to alleviate joint pain using phospholipids and roe extract
US8481072B2 (en)	2009-07-23	2013-07-09	U.S. Nutraceuticals, LLC	Composition and method to alleviate joint pain
US9402857B2 (en)	2009-07-23	2016-08-02	U.S. Nutraceuticals, LLC	Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
UY32989A (es)	2009-10-29	2011-04-29	Acasti Pharma Inc	Coposiciones terapéuticas concentradas de fosfolípidos
AU2009354456B2 (en) *	2009-10-30	2014-05-08	Tharos Ltd	Solvent-free process for obtaining phospholipids and neutral enriched krill oils
MX2012005460A (es) *	2009-11-11	2012-07-20	Dynasep Inc	Metodo de secado con acetona eficiente en energia.
KR101204391B1 (ko) *	2010-03-10	2012-11-26	인성실업(주)	지질추출장치，이 장치를 가지는 어분제조기
WO2012029898A1 (ja) *	2010-09-01	2012-03-08	日本水産株式会社	アルコール性障害緩和剤
CN102071101B (zh) *	2011-01-21	2012-10-10	山东科芮尔生物制品有限公司	一种从南极磷虾中提取富含磷脂的磷虾油的方法
US20120231087A1 (en)	2011-03-07	2012-09-13	Olympic Seafood	Compositions And Methods for Nutritional Supplementation
US20120284165A1 (en) *	2011-05-06	2012-11-08	LiveFuels, Inc.	Method for removing carbon dioxide from ocean water and quantifying the carbon dioxide so removed
US9487716B2 (en)	2011-05-06	2016-11-08	LiveFuels, Inc.	Sourcing phosphorus and other nutrients from the ocean via ocean thermal energy conversion systems
CN102224855B (zh) *	2011-05-13	2013-05-08	中国海洋大学	一种南极磷虾中脂质的富集方法
WO2013033618A1 (en)	2011-09-02	2013-03-07	Arctic Nutrition As	Lipid compositions with high dha content
WO2013149384A1 (en) *	2012-04-05	2013-10-10	Nippon Suisan Kaisha, Ltd.	Brain atrophy prevention agent
RU2506314C2 (ru) *	2012-05-04	2014-02-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ)	Способ качественного и количественного анализа липидов, прочносвязанных с геномной днк
CN102732382B (zh) *	2012-07-18	2013-07-03	山东师范大学	一种从南极磷虾中提取蜡的方法
CN102731360B (zh) *	2012-07-18	2015-03-25	山东师范大学	一种从南极磷虾中提取虾青素的方法
EP2897595B1 (en) *	2012-09-24	2020-06-03	Aker Biomarine Antarctic As	Omega -3 compositions
WO2014052357A1 (en) *	2012-09-25	2014-04-03	The Johns Hopkins University	Methods for extraction of lipids from wet algal biomass
WO2014184655A1 (en)	2013-02-07	2014-11-20	Olympic Seafood As	Methods for using crustacean phospholipid-peptide-protein complexes
AU2014203179C1 (en)	2013-06-14	2017-05-04	Aker Biomarine Antarctic As	Lipid extraction processes
WO2015023783A1 (en)	2013-08-13	2015-02-19	Darling Ingredients Inc.	Lipid extraction
CN103773596B (zh) *	2013-12-31	2016-05-18	上海复力生物医药科技有限公司	磷虾油的制备方法
GB201400431D0 (en)	2014-01-10	2014-02-26	Aker Biomarine As	Phospholipid compositions and their preparation
CA2938097A1 (en)	2014-02-11	2015-08-20	Enzymotec Ltd.	Krill oil preparations with optimal mineral and metal composition, low impurities and low and stable tma levels
CN103864841A (zh) *	2014-03-12	2014-06-18	威海博宇食品有限公司	一种从水产动物卵中提取与精制磷脂的方法
CN106535650A (zh)	2014-04-30	2017-03-22	恩兹莫特克有限公司	磷虾油制剂和它们的用途
US9701923B2 (en)	2014-10-24	2017-07-11	Darling Ingredients Inc.	Lipid extraction
PL3256003T5 (pl)	2015-02-11	2025-11-17	Aker Biomarine Human Ingredients As	Sposoby ekstrakcji lipidów
WO2016128838A2 (en) *	2015-02-11	2016-08-18	Aker Biomarine Antarctic As	Lipid compositions
CN105152910B (zh) *	2015-07-23	2017-06-30	山东师范大学	一种从脱脂南极磷虾中提取及检测棕榈酸的方法
EP3504309A4 (en) *	2016-08-24	2020-07-29	Samuel Philip	IMPROVED OIL TREATMENT AND EXTRACTION PROCESS
WO2018183815A1 (en) *	2017-03-31	2018-10-04	Avoca Llc	Methods for the preparation of phospholipid enriched krill compositions.
US10709148B2 (en)	2017-12-04	2020-07-14	Rimfrost Technologies	Method for producing a protein phospholipid complex from a crustacean catch
CN108130193B (zh) *	2017-12-21	2021-04-02	山东师范大学	一种提高南极磷虾油脂提取率的方法
CN121313680A (zh)	2017-12-22	2026-01-13	法姆灵国际有限公司	脂质组合
CN109053420B (zh) *	2018-08-21	2021-03-16	浙江海洋大学	一种从桡足类中提取dha和epa的方法
JP7610770B2 (ja) *	2019-02-12	2025-01-09	アーケルバイオマリンヒューマンイングリーディエンツアクティーゼルスカブ	高レベルの遊離脂肪酸を含むオキアミ抽出物から濃縮された治療用リン脂質組成物を製造する方法
CN110361497B (zh) *	2019-08-02	2021-06-25	山东师范大学	一种南极磷虾中氨基酸的检测方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT331374B (de)	1972-12-22	1976-08-25	Studiengesellschaft Kohle Mbh	Verfahren zur gewinnung von fetten und olen aus pflanzlichen und tierischen produkten
JPS5248191B2 (ja) *	1974-12-27	1977-12-08
JPS53112195A (en) *	1977-03-10	1978-09-30	Nippon Paint Co Ltd	Method for producing food for fish
CA1098900A (en)	1977-12-14	1981-04-07	Sergei V. Rogozhin	Method for the processing of krill to produce protein, lipids and chitin
NO147365C (no) *	1980-11-27	1983-03-30	Jan Raa	Fremgangsmaate til fremstilling av astaxanthin i en form som er egnet for innlemmelse i for for oppdrettfisk.
JPS59501908A (ja) *	1982-10-25	1984-11-15	ヘルグレン・ラルス・グスタ−ヴ・インゲ	クリーニング用酵素組成物
JPS59196032A (ja) *	1983-04-23	1984-11-07	Fumio Nishikawa	オキアミの変性防止及び鮮度保持の方法
JPS6035057A (ja) *	1984-06-27	1985-02-22	San Ei Chem Ind Ltd	黄橙色ないし赤橙色色素の製法
US5006281A (en)	1985-03-26	1991-04-09	Century Laboratories, Inc.	Process for the production of a marine animal oil
JPS6390598A (ja) *	1986-10-03	1988-04-21	日本油脂株式会社	ドコサヘキサエン酸を含む脂質の製造法
JPS63162793A (ja) *	1986-12-26	1988-07-06	焼津水産化学工業株式会社	脂質の抽出方法
JP2963152B2 (ja)	1990-06-28	1999-10-12	クロリンエンジニアズ株式会社	オキアミからの色素の抽出分離方法
DE4219360C2 (de)	1992-06-12	1994-07-28	Milupa Ag	Verfahren zur Gewinnung von Lipiden mit einem hohen Anteil von langkettig-hochungesättigten Fettsäuren
JPH07107920A (ja) *	1993-10-12	1995-04-25	Nichiwa Sangyo Kk	鶏用飼料
RU2089208C1 (ru) *	1994-05-17	1997-09-10	Коми научный центр Уральского отделения РАН	Способ выделения липидов
JPH08198754A (ja) *	1995-01-23	1996-08-06	Yakult Honsha Co Ltd	脳機能改善剤
JP3398248B2 (ja) *	1995-03-16	2003-04-21	新日本石油株式会社	キサントフィル化合物の精製方法
JPH09143063A (ja) *	1995-11-22	1997-06-03	Kose Corp	外用に適する組成物
JPH09308459A (ja) *	1996-05-20	1997-12-02	Nof Corp	高度不飽和脂肪酸含有栄養組成物
US6055936A (en) *	1997-01-21	2000-05-02	Collin; Peter Donald	Sea cucumber carotenoid lipid fractions and process
CA2251265A1 (en) *	1998-10-21	2000-04-21	Universite De Sherbrooke	Process for lipid extraction of aquatic animal tissues producing a dehydrated residue

1998
- 1998-10-21 CA CA002251265A patent/CA2251265A1/en not_active Abandoned
1999
- 1999-10-21 BR BRPI9914699-1A patent/BR9914699B1/pt not_active IP Right Cessation
- 1999-10-21 UA UA2001042679A patent/UA75029C2/uk unknown
- 1999-10-21 US US09/830,146 patent/US6800299B1/en not_active Expired - Lifetime
- 1999-10-21 DK DK99952180T patent/DK1123368T3/da active
- 1999-10-21 EP EP99952180A patent/EP1123368B1/en not_active Expired - Lifetime
- 1999-10-21 RU RU2001113503A patent/RU2236441C2/ru not_active IP Right Cessation
- 1999-10-21 ES ES99952180T patent/ES2306527T3/es not_active Expired - Lifetime
- 1999-10-21 DE DE1999638504 patent/DE69938504T2/de not_active Expired - Lifetime
- 1999-10-21 CN CNB998124176A patent/CN1269940C/zh not_active Expired - Fee Related
- 1999-10-21 PL PL347396A patent/PL201771B1/pl unknown
- 1999-10-21 WO PCT/CA1999/000987 patent/WO2000023546A1/en not_active Ceased
- 1999-10-21 AU AU64552/99A patent/AU765464B2/en not_active Ceased
- 1999-10-21 AT AT99952180T patent/ATE391763T1/de active
- 1999-10-21 KR KR10-2001-7004998A patent/KR100454899B1/ko not_active Expired - Fee Related
- 1999-10-21 PT PT99952180T patent/PT1123368E/pt unknown
- 1999-10-21 JP JP2000577261A patent/JP4181305B2/ja not_active Expired - Fee Related
2001
- 2001-04-18 NO NO20011915A patent/NO321481B1/no not_active IP Right Cessation
- 2001-04-20 ZA ZA200103235A patent/ZA200103235B/en unknown
2007
- 2007-11-02 JP JP2007285980A patent/JP5172281B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1324394A (zh)	2001-11-28
RU2236441C2 (ru)	2004-09-20
HK1038765A1 (en)	2002-03-28
ATE391763T1 (de)	2008-04-15
CA2251265A1 (en)	2000-04-21
PT1123368E (pt)	2008-07-18
EP1123368A1 (en)	2001-08-16
AU6455299A (en)	2000-05-08
KR100454899B1 (ko)	2004-11-06
JP5172281B2 (ja)	2013-03-27
KR20010103615A (ko)	2001-11-23
DK1123368T3 (da)	2008-08-04
BR9914699A (pt)	2001-07-10
JP2008150586A (ja)	2008-07-03
ZA200103235B (en)	2002-06-20
EP1123368B1 (en)	2008-04-09
AU765464B2 (en)	2003-09-18
DE69938504D1 (de)	2008-05-21
UA75029C2 (en)	2006-03-15
NO20011915L (no)	2001-06-21
US6800299B1 (en)	2004-10-05
WO2000023546A1 (en)	2000-04-27
JP4181305B2 (ja)	2008-11-12
JP2002527604A (ja)	2002-08-27
PL347396A1 (en)	2002-04-08
ES2306527T3 (es)	2008-11-01
DE69938504T2 (de)	2009-06-10
CN1269940C (zh)	2006-08-16
NO321481B1 (no)	2006-05-15
NO20011915D0 (no)	2001-04-18
PL201771B1 (pl)	2009-05-29

Publication	Publication Date	Title
BR9914699B1 (pt)	2009-12-01	método para extração de frações de lipìdios de material de animais marinhos e aquáticos, extrato de lipìdio de cril, uso do mesmo, fração de lipìdio, e, uso da mesma.
US6055936A (en)	2000-05-02	Sea cucumber carotenoid lipid fractions and process
CA2392956C (en)	2010-01-05	Method for purifying marine mammal oil enriched in omega 3 fatty acids and compositions comprising same
Kraffe et al.	2004	Fatty acids of serine, ethanolamine, and choline plasmalogens in some marine bivalves
Al-Hasan et al.	1987	Correlative changes of growth, pigmentation and lipid composition of Dunaliella salina in response to halostress
Narayan et al.	2008	Composition, functionality and potential applications of seaweed lipids
CA2346979C (en)	2009-07-07	Method of extracting lipids from marine and aquatic animal tissues
US20080268117A1 (en)	2008-10-30	Method of purifying oils containing epa and dha
HK1038765B (en)	2008-09-12	Method of extracting lipids from marine and aquatic animal tissues
Valenzuela et al.	1993	Technological challenges to assess n-3 polyunsaturated fatty acids from marine oils for nutritional and pharmacological use
MXPA01003955A (en)	2001-11-21	Method of extracting lipids from marine and aquatic animal tissues
JPH01160989A (ja)	1989-06-23	ドコサヘキサエノイルホスファチジルコリンの製造法
Kishimura	2012	Enzymatic properties of starfish phospholipase A2 and its application
Hayashi et al.	2002	Distribution of docosahexaenoic acid in DHA-enriched Euglena gracilis
HK1079963A (en)	2006-04-21	Method for purifying marine mammal oil enriched in omega 3 fatty acids and compositions comprising same

Legal Events

Date	Code	Title	Description
2008-12-09	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2009-07-14	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2010-01-12	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/01/2010, OBSERVADAS AS CONDICOES LEGAIS.
2019-08-13	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 20A ANUIDADE.
2019-12-03	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2536 DE 13-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.